Relationship Between Dihydropyrimidine Dehydrogenase Gene Polymorphism and Toxicities in Cancer Patients Receiving 5-Fluorouracil
Objective: Dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme that degrades uracil, thymine, and 5-fluorouracil, which are important for treating gastric, colorectal, and breast cancers. In this study, we aimed to determine the association between chemotherapy-related toxicities and DPD...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BUCA SEYFI DEMIRSOY TRAINING AND RESEARCH HOSPITAL
2024-08-01
|
| Collection: | Forbes Tıp Dergisi |
| Sujets: | |
| Accès en ligne: | https://jag.journalagent.com/forbes/pdfs/FJM_5_2_87_94.pdf |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|